GGrantIndex
Sort

39,280 grants matching leukemia

Heterogeneity of bone marrow cavities shaping the hematopoietic microenvironment

$714,681
Charles P Lin · Massachusetts General Hospital · R01 · FY2025 · HL

Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy

$714,516
Daniel Fowler · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Research Studies of Erythropoiesis and Iron Biology.

$714,231
Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity

$714,178
William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2019 · GM

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

$714,052
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification

$714,036
Yabing Chen · University Of Alabama At Birmingham · R01 · FY2023 · HL

Understanding the role of the blood vascular system and endothelial cells in early thymus regeneration after cytotoxic treatments using novel intravital imaging techniques

$713,940
Joel A. Spencer · University Of California, Merced · R01 · FY2025 · HL

Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma

$713,895
Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

The Biology of Mutant STAT6 in Follicular Lymphoma

$713,700
Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Multiscale Modeling of Myelodysplastic Syndromes

$713,684
Seth Joel Corey · Virginia Commonwealth University · R01 · FY2018 · HL

Pediatric Clinical Research Scholar Program - Washington

$713,540
Naomi L Luban · Children'S Research Institute · K12 · FY2006 · RR

Predictive Markers in Metastatic Renal Cancer

$713,221
Frederic M. Waldman · University Of California, San Francisco · R01 · FY2008 · CA

SIGNALING PATHWAYS UTILIZED BY V-ABL AND BCR-ABL

$713,043
Columbia University Health Sciences · P01 · FY2000 · CA

NHGRI/DIR Genomics Core

$712,860
Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2014 · HG

Protein Tyrosine Dephosphorylation & Signal Transduction

$712,640
Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2010 · CA

Targeting cancer neoantigens in patients with myeloid malignancies

$712,168
Vid Leko · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Human natural killer cells: Advancing biology and clinical applications

$712,108
Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2019 · CA

Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood

$712,071
Rolf Muller · Biofluidica, Inc · R44 · FY2018 · CA

Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation

$711,892
Brian C Betts · Roswell Park Cancer Institute Corp · R01 · FY2025 · HL

KSHV Latency Regulation

$711,722
Kenneth M Kaye · Brigham And Women'S Hospital · R01 · FY2022 · AI

Role of Phase separation by fusion oncoproteins in oncogenesis

$711,598
Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

North Shore CCOP

$711,448
Vincent P Vinciguerra · Feinstein Institute For Medical Research · U10 · FY2013 · CA

Stem Cell Graft Engineering to Treat Sickle Cell Disease

$711,438
Suzanne T Ildstad · Regenerex, Llc · R42 · FY2008 · HL

Hematopathology Diagnosis

$711,370
Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging

$711,338
Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA